… of severe COVID‐19, and ongoing anticoagulant use might be … use was not associated
with reduced risk of severe COVID‐19, indicating that prognosis would not be modified by early …

… FDA did emphasize in their press release that this antibody was not authorized for
hospitalized COVID-19 patients and that the use of this antibody might be associated with worse …

… One strategy that has received considerable attention in the face of COVID-19 is the use of
… The treatment uses plasma from a patient who has survived COVID-19 infection to provide …

… use particulate respirators such as those certified N95 or FFP2 when performing aerosol-generating
procedures and to use … symptoms are advised to use medical masks both in health …

… Human convalescent plasma uses antibodies harvested … with COVID-19 to treat currently
infected patients with COVID-19. … the use of convalescent plasma in individuals with COVID-19 …

… We showed that during the earliest phase of the global outbreak (January-March), COVID-19 …
Accordingly, COVID-19 growth rates consistently decreased with stringent containment …

… Many effective and evidence-based psychological interventions for mental disorders were
available for use before the COVID-19 pandemic, including those promoted by WHO, such as …

… We realized preparing ICUs for patients with COVID19 had … we prepared to cohort all COVID-19
patients in the medical ICU … Commons licence and your intended use is not permitted by …

… Our early experiences from the COVID-19 pandemic showed significant morbidity in an …
Our results support the use of low absolute value of lymphocyte counts as a reference index …

… coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19)… considered at risk for COVID-19 infection. The …